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1. Introduction
Glaucoma is an acquired optic neuropathy in which destruction of ganglion cells and fibers
leads to irreversible visual field loss. The prevalence of glaucoma, a leading cause of visual
impairment and blindness worldwide [1,2], in the general population is about 2%. Increased
intraocular pressure (IOP) is a primary risk factor for glaucoma development. IOP evalua‐
tion is used to assess disease control and treatment response, and lowering IOP has resulted
in reducing the rates of disease progression over 5 years [3-7]. These data confirmed that ele‐
vated IOP is a pathophysiologic basis for glaucoma; therefore, accurate IOP measurement is
critical in glaucoma.
Goldmann applanation tonometry (GAT), the gold standard for measuring IOP, estimates
the IOP based on the force needed to flatten the corneal apex to a diameter of 3.06 mm. This
area was chosen empirically to offset the surface tension of the tear film, which tends to
draw the tonometry tip toward the eye, and the corneal and ocular rigidity, which affect the
applanation force needed independent of the IOP level. When applanating this area, a gravi‐
tational force of 0.1 g corresponds to an IOP of 1 mmHg. Goldmann and Schmidt [8] found
that when large variations in the central corneal thickness (CCT) occur, the accuracy of the
GAT values can be affected.
The corneal rigidity affects the IOP measurements. The corneal biomechanics are more com‐
plex than central pachymetry alone and include viscosity, bioelasticity, hydration, regional
pachymetry, and likely other as yet undetermined factors [9,10].
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2. Corneal anatomy and histology
The cornea, the primary refractive ocular structure that contributes to focusing the external
images on the retina, measures 11 to 12 mm horizontally, 10 to 11 mm vertically, and is
about 0.5 mm thick centrally. The corneal thickness increases gradually toward the periph‐
ery to about 0.7 mm. Corneal nutrition depends on both glucose diffusing from the aqueous
humor and oxygen supplied from the air through the tear film and in the peripheral cornea
from the limbal blood vessels [11]. The cornea accounts for more than two thirds of the total
ocular refractive power. Any slight change in the corneal contour can cause a substantial
change in the ocular refractive power. The corneal optical properties are determined by its
transparency, surface smoothness, contour, and refractive index.
The cornea is comprised of five layers: the epithelium, Bowman’s layer, stroma, Descemet’s
membrane, and endothelium. The epithelium, the most anterior layer, is comprised of non-
keratinizing stratified squamous epithelial cells. The epithelium and tear film form an opti‐
cally smooth surface. The Bowman’s layer is the most anterior part of the corneal stroma,
and is adjacent to the epithelial basement membrane.
The structural and optical features depend mainly on the structure and composition of the
corneal stroma, which represents up to 90% of the corneal thickness. Corneal transparency
basically depends on the regular spacial distribution of the stromal cells and the stromal la‐
mellae, and also on the water content of the stroma, that must be kept at a constant level of
about 78%. The keratocytes are highly scattered and do not affect transparency. The lattice
structure of the corneal collagen fibers, within a distance of 0.5 microns of the visible wave‐
length, is responsible for corneal transparency. Any decrease (dehydration) or increase (ede‐
ma) in this distance results in a loss of transparency. Fibrillar collagen types I and V, which
are intertwined with type VI collagen filaments (collagen types III, XII, and XIV have also
been found in the stroma) and corneal proteoglycans (mainly decorin associated with der‐
matan sulfate and lumican associated with keratan sulfate), are the fundamental compo‐
nents of the extracellular matrix (ECM).
Negatively charged stromal glycosaminoglycans tend to repel each other, producing the
corneal swelling pressure (SP) (of about 50 mmHg in the excised cornea), and can absorb
and retain large amounts of water. The keratocytes lie between the corneal lamellae and syn‐
thesize both collagen and proteoglycans.
The diameter of each collagen fiber and the distance between the collagen fibers are homo‐
geneous and measure less than half of the wavelength of the visible light (400-700 nm). This
anatomic distribution of fibers is responsible for the fact that the incident light rays scattered
by each collagen fiber are cancelled by the interference of other scattered rays, which allows
the incident light to pass through the cornea without optical disruption.
Descemet’s membrane, the basement membrane of the endothelium, is highly elastic and
can withstand high pressure. When injured, it can regenerate.
The endothelium, the innermost corneal layer, is a monolayer of hexagonally shaped endo‐
thelial cells arranged in a mosaic pattern. The integrity of this layer and the correct function
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of the endothelial pump, which is linked to the ion-transport system controlled by enzymes
such as Na+, K+-ATPase, are necessary to maintain the stability of the corneal water content.
Therefore, the endothelium prevents corneal edema by both the barrier and the pump func‐
tions. The pump function generates the so-called corneal imbibition pressure (IP), a negative
pressure that draws fluid into the cornea. The IP is equal to the SP in the excised cornea. In
vivo, however, the IP is lower than the SP because of the compressive effect of the IOP on
the cornea. The relationship between these three parameters is described by the equation:
IP = IOP - SP (1)
Although the regulation of the corneal hydration is maintained largely by the function of the
endothelial pump, the epithelial barrier effect, the surface evaporation, the IOP level, and
the SP also play a role.
3. Impact of CCT on tonometry
The Ocular Hypertension Treatment Study (OHTS) [13] was a multicenter, randomized,
prospective clinical trial of the efficacy of topical ocular hypotensive medications in delaying
or preventing glaucoma onset in patients with ocular hypertension (OHT). Based on the
OHTS, the CCT measured by pachymetry (Figure 1) has become important in glaucoma,
and the study showed that the CCT is a significant predictor of the patients with OHT who
are at higher risk of developing glaucoma, with a hazard ratio of 1.82 for each 40-µm thin‐
ning of the CCT.
Figure 1. Ultrasound Pachymeter DGH 500 (Pachette™)
Eyes with a CCT of 555 µm or less had a three-fold greater risk of developing glaucoma
compared with eyes that had a CCT exceeding 588 µm. In the multivariate model of baseline
characteristics predictive of conversion oh OHT to glaucoma, the CCT had the greatest im‐
pact on the risk. These findings were confirmed in the European Glaucoma Prevention
Study [14].
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The CCT can be easily and accurately measured, it remains quite constant over a patient’s
lifetime, and, thus, just one CCT measurement is adequate in most patients. It is not clear
why the CCT is such a strong predictor of the development of primary open-angle glauco‐
ma (POAG) in OHT patients. In a multivariable model including age, baseline GAT IOP, op‐
tic disc topography (cup to disc [c/d] ratio), and visual field (pattern standard deviation
[PSD]), although the CCT and IOP have independent effects on the risk of developing
POAG, the two factors interact. Nevertheless, because GAT measurements depend on the
CCT, it was impossible in the original model to completely disassociate the effects of both.
These findings prove that CCT is an independent risk factor for glaucoma development. The
CCT artifacts the GAT, so the IOP may be overestimated or underestimated in thick or thin
corneas, respectively.
In 1975, Ehlers cannulated 29 eyes undergoing cataract surgery and found differences be‐
tween the cannulated IOP and GAT IOP that were related to the CCT [15]; the GAT IOP was
most accurate when the CCT was 520 µm. These results indicated that the CCT varies
among individuals, and that this variations significantly affect the GAT IOP (Figure 2);
therefore, deviations from the 520-µm reference value produced under- and overestimates
of 7 mmHg for every 100 µm of deviation.
Figure 2. Goldmann applanation tonometer on a slit-lamp.
Investigators have attempted to design nomograms or correction formulas to account for the
effect of CCT on GAT-IOP measurement [15-18], but none has been satisfactory.
The use of the available formulas to obtain a CCT-corrected GAT IOP does not improve the
accuracy of the models to predict the risk of glaucoma development [19]. The predictive
abilities were similar between the original OHTS model that included CCT, and other mod‐
els that did not include the CCT but only the CCT-corrected IOP. This may mean that the
CCT is relatively unimportant in the final predictive ability of the multivariable model as
long as the CCT-corrected IOP is included. For example, a model including the IOP values
corrected by the Ehlers formula [15] (a commonly used CCT correction formula that exclud‐
ed the CCT) had a predictive ability almost identical to the original OHTS model. Such a re‐
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sult could hardly indicate a major true independent contribution of CCT as a prognostic
factor of glaucoma development.
The fundamental concept supporting this correction formula is that as corneas become thin‐
ner, the GAT measurements become too low. If the CCT is an average value, the GAT value
is essentially correct, and if the cornea is thicker than average, the GAT overvalues the true
manometric IOP. Although the Ehlers formula was based on manometric data, the weakness
of the formula arises from the small number of subjects studied and the high degree of vari‐
ability among the subjects. Ehler’s data showed a tendency for the Goldmann IOP to in‐
crease with increasing CCTs; however, a close look at that data indicates that many subjects
clearly defy that trend, i.e., the Goldmann values were too low in some subjects with thick
corneas and too high in some with thin corneas. The correlations between the IOP and CCT
with Ehler’s data and data from similar studies are too low to allow definitive clinical deci‐
sion-making based on these formulas. However, adjusting the IOP using CCT-based formu‐
las has resulted in poorer agreement with Pascal dynamic contour tonometry, a slit-lamp
mounted tonometer for measuring IOP wich seems to be independent of the corneal proper‐
ties (Figure 3), compared with unadjusted GAT IOP values [20]. It suggested that, although
the CCT may be useful in population analyses, CCT-based correction formulas should not
be applied to individuals.
Figure 3. Dinamic contour tonometer.
CCT correction formulas for GAT measurements are probably of little value in clinical prac‐
tice [21]. It might be advantageous to incorporate the risk information from validated pre‐
dictive models of glaucoma development or progression [19,21], so clinicians have to
account for baseline older age, higher IOP, larger vertical c/d ratio, thinner CCT, and greater
PSD in the visual field. The hypothesis that CCT is a true independent risk factor for glauco‐
ma is currently not validated and requires further investigation.
In addition, the CCT is becoming more important clinically because of the large number of pa‐
tients who undergo laser in situ keratomileusis (LASIK), which causes high IOP elevations in‐
traoperatively [22] and a permanent corneal thinning, that, therefore, affects the IOP evaluation.
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Because the IOP is an important risk factor for glaucoma, accurate measurement is important,
and it can be achieved by intraocular manometry; however, this is an invasive method that obvi‐
ously cannot be used in a clinical setting,
The only way to fully evaluate the possible independent role of CCT as a prognostic factor for
glaucoma development is to include in the predictive model the IOP measurements obtained by
a CCT-independent tonometer. The Pascal dynamic contour tonometer (DCT), is a slit-lamp-
mounted, nonapplanation, digital contact tonometer that provides continuous tonometry re‐
cordings that measure the IOP and the ocular pulse amplitude, which is the difference between
the minimal and maximal values of the pulsatile IOP wave contour, and does not require cor‐
neal applanation and the DCT IOP measurements seem to agree closely with manometric meas‐
urements [23]. Therefore, including DCT measurements with the CCT in a predictive model for
glaucoma might better assess the true independent value of CCT compared with use of only the
CCT-corrected GAT values. This has been investigated in patients undergoing phacoemulsifi‐
cation, that had the anterior chamber cannulated in a closed system and the IOP was set to 15, 20,
and 35 mmHg by a water column. The IOP measurements then were taken by DCT. The results
showed that the DCT agree well with the intracameral IOP. Interestingly, the CCT had a low but
significant effect on the DCT measurements [23].
The DCT measurement principle is based on contour matching, which assumes that if the eye
were enclosed by a contoured, tight-fitting shell, the forces generated by IOP would act on the
shell wall. Replacing part of the shell wall with a pressure sensor would enable measurement of
these forces and therefore the IOP. The DCT has a central gauge surrounded by a contoured
plastic tip that is in contact with the cornea and creates a tight-fitting shell. The DCT compen‐
sates for all forces exerted on the cornea and an electronic sensor measures IOP independent of
the corneal properties.
4. Corneal thickness and glaucoma
Most of the knowledge regarding the impact of corneal thickness in glaucoma is referred to
CCT; however, Jordan et al. [24] found differences between the OHT and normal tension
glaucoma (NTG) groups in central and paracentral corneal thicknesses measured by optical
slip scan pachymetry. The study corroborated differences in CCT between OHT and NTG
but also found that the corresponding paracentral quadrants differed significantly between
groups. Patients with NTG had overall thinner corneas and those with OHT had overall
thicker corneas. Is the corneal thickness an independent risk factor for glaucoma?
Goldmann first suggested in 1957 that the IOP measured by applanation tonometry might
be affected by the CCT [25]. He found that IOP measurements in patients with thin corneas
tended to be underestimated but overestimated in those with thick corneas.
In the OHTS, the GAT IOP was used to determine participant eligibility, guide treatment de‐
cisions, and construct a model predictive of POAG development. Had the OHTS been car‐
ried out with a perfectly accurate, cornea-independent tonometer, which does not exist, the
IOP might have been a more powerful predictor of POAG development and the CCT might
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have been a less powerful predictor. Some investigators interpreted the OHTS results to in‐
dicate that the CCT is an independent risk factor for glaucoma development. Because the
GAT measurements ultimately depend on the CCT, Medeiros and Weinreb [26] stated that it
is impossible, based on the original model, to disassociate the effects of both. Some groups
have evaluated [19,27,28] whether the OHTS prediction model could be improved using
CCT-corrected IOP using previously published formulas (Table 1), evaluated using the c sta‐
tistics (a measure of concordance), and calibration chi-squares. The c statistic is the fraction
of patients with an outcome among pairs of patients, in which one has the outcome and one
does not; the patient with the higher predictive value is classified as the one with the out‐
come. The c statistic varies between 0.5 when a model provides no information and 1.0 in
sensible models. The CCT also remained a significant predictor of glaucoma development in
a multivariable model that included the CCT-corrected IOP.
CCT in microns IOP correction in mm Hg
445 7
455 6
465 6
475 5
485 4
495 4
505 3
515 2
525 1
535 1
545 0
555 -1
565 -1
575 -2
585 -3
595 -4
605 -4
615 -5
625 -6
635 -6
645 -7
Table 1. Correction values for IOPs based on CCT [ 8,17].
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Medeiros and Weinreb [26] argued that other factors besides corneal thickness such as cor‐
neal elasticity and viscoelasticity might affect tonometric readings and the formulas to cor‐
rect the GAT IOP [19] do not fully consider these factors [19, 27, 28]. The DCT measurements
have been proposed and agree closely with the manometric measurements [20]. Therefore,
the inclusion of DCT measurements along with corneal thickness in a model predictive of
glaucoma might better assess the true independent value of IOP. A biologic link might exist
between some corneal parameters such as the thickness or the viscoelastic properties and
the structure/deformability/physiology of the lamina cribosa and peripapillary sclera.
It is noteworthy that in the Early Manifest Glaucoma Trial (EMGT) the IOP was not used to
determine patient eligibility or treatment decisions, and thus the possible effect of the CCT
on GAT measurements was less likely to affect the incidence of glaucoma progression. In
the EMGT, the CCT was an independent factor predictive of POAG progression [29]. In the
population-based, longitudinal Barbados Eye Studies, the CCT (measured 9 years after the
recruitment) was an independent risk factor for development of glaucoma [30]. In the popu‐
lation-based Los Angeles Latino Eye Study (LALES), the prevalence of glaucoma was higher
among individuals with thin CCTs than among individuals with normal or thick CCTs
across all IOP levels [31]. The LALES, which investigated whether adjusting each IOP indi‐
vidually for CCT using the Doughty and Zaman algorithm [16] changed this relationship,
reported almost no change in the association between a thin CCT and a higher prevalence of
glaucoma. This algorithm showed that 2.5 mmHg was correlated with a 50-µm difference
from the baseline CCT. Each of these corrective factors had proponents, and the use of algo‐
rithms to correct for the IOP based on the CCT became popular. The LALES concluded that
the CCT is an independent factor itself [31]. The findings of the EMGT, Barbados Eye Stud‐
ies, and LALES suggest that the effect of CCT on the glaucoma development risk is caused
by more than just a tonometry artifact.
5. Corneal biomechanics
Ocular biomechanics is an increasingly important field. Overt corneal biomechanical prob‐
lems have long been seen in keratoconus and corneal ectasia after corneal refractive sur‐
gery [32].
In keratoconus, there are clear changes in the corneal collagen, and the cornea loses rigidity
over time and becomes ectatic; in corneal ectasia, the ablation of some corneal stroma can
weaken the cornea and result in progressive corneal deformation [33]. In refractive surgical
practice, patients with preexisting ectasia usually are excluded from treatment. However, in‐
dividual variations in biomechanical integrity and postoperative wound healing preclude
preoperative identification of all potentially vulnerable patients. There is considerable but
mostly indirect evidence suggesting that the biomechanical corneal properties vary with
age. Quantifying the biomechanical corneal properties is difficult, but the available evidence
supports corneal stiffening with age; in other words, there is an increment in Young’s mod‐
ulus [34], the ocular rigidity coefficient, that expresses the elastic properties of the globe
[35,36], the cohesive tensile strength, and the breaking force of a tissue [37].
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Young’s modulus, also known as the tensile modulus, is a measure of the stiffness of an
elastic material and is a parameter used to characterize elastic materials. Perhaps the single
best descriptor of a given material’s biomechanical properties at low strain is its Young’s
modulus (E), which is defined as the ratio of stress to strain or
Young 'smodulus(E )= stress / strain
where stress is an applied force (load/unit area), and strain is the deformation of the materi‐
al to which stress has been applied (displacement/unit length). This parameter depends on
the material’s physical properties and dimensions. Importantly, when stress is applied and
removed, elastic materials follow the same path during deformation and relaxation and ulti‐
mately recover the original shape. Viscoelastic materials, such as the cornea, also can recover
the original shape after stress is removed, but the relaxation path differs from the deforma‐
tion path; therefore, the relationship between stress and strain is nonlinear, and stiffening
occurs as strain increases [38-40] (Figure 4). This behavior, referred to as corneal hysteresis
(CH), results from dissipation of energy as heat in the material.
Figure 4. Here, it can be seen the relationship between stress and strain is linear in an elastic behaviour and nonlinear
in a viscoelastic behaviour.
The GAT IOP measurement, obtained from the force needed to applanate the cornea, is
based on a number of assumptions about corneal deformability. The corneal mix of collagen
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types, corneal hydration, collagen fibril density, ECM, and other factors vary among indi‐
viduals. In some patients, these factors dwarf the effect of the CCT on the accuracy of the
GAT IOP value. In fact, the effect of the corneal thickness on GAT measurements may be
less important than the effect of variations in corneal elasticity [41].
CH is a measure of the viscoelastic properties of the corneal tissue together with the corneal
resistance factor (CRF), i.e., the “energy absorption capability” of the cornea, and indicates
the biomechanical integrity. The Ocular Response Analyzer (ORA) (Reichert Ophthalmic In‐
struments, Inc., Buffalo, NY) provides both parameters (Figure 5).
Figure 5. Ocular response analyzer.
The ORA, which measures some of the corneal biomechanical properties in vivo, uses a 25-
millisencond (ms) air pulse to apply pressure to the cornea. The air pulse causes the cornea
to move inward, past applanation and into a slight concavity, before returning to the normal
curvature. Corneal deformation is recorded via an electro-optical infrared detection system
similar to classic air-puff tonometry. The ORA acquires corneal biomechanical data by quan‐
tifying this differential inward and outward corneal response to the air pulse over about 20
ms (Figure 6).
Figure 6. This picture shows the measurements done by ORA.
Because of the dynamic nature of the measurement process, viscous damping in the cornea
causes delays in the inward and outward applanation events (energy absorption). Millisec‐
onds after the first applanation, the air pump that generated the air pulse also shuts down,
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and the air pressure applied to the eye decreases in an inverse-time symmetric fashion.
However, before that decrease, the cornea is indented substantially as the air pressure peaks
about 3 ms after applanation. As the pressure decreases from its peak, the cornea passes
through a second applanated state while returning to the normal convex curvature. This al‐
lows detection of a second applanation point. Using the first applanation pressure point (P1)
and the second applanation pressure point (P2) [42,43] (Figure 7), the ORA generates two
separate IOP output parameters, and the difference between the two pressures is CH.
Figure 7. This picture shows de P1 and P2 points. Hysteresis is also showed.
The Goldmann-correlated IOP (IOPg) is the average of the inward (P1) and outward (P2) ap‐
planation pressures. This parameter is closely correlated with the GAT IOP.
The CH measurement also provides a basis for two additional new parameters: the corneal-
compensated IOP (IOPcc), an IOP measurement that is less affected by corneal properties
than other tonometric methods, such as GAT, and CRF, an index of corneal resistance to de‐
formation derived from the formula P1 x kP2, where k is the constant determined from em‐
pirical analysis of the relationship between both P1 and P2 and CCT to develop a corneal
parameter more strongly associated with CCT than CH [44].
The CH in patients with glaucoma and in those with acquired optic nerve head (ONH) pits
is lower than in normal controls [43, 45]. Other authors also have found that the CH predicts
visual field damage progression. However, other studies using the ORA have reported that
the CRF and CH did not change significantly when the IOP was lowered using topical anti‐
glaucoma drugs and that the relationship between the GAT IOP and CRF or CH is weak and
unchanged by ocular hypotensive drugs [46].
6. Corneal and refractive surgeries
The changes in the GAT IOP after corneal refractive surgery have been studied because of
the large number of patients who undergo laser refractive procedures. In corneal laser exci‐
mer refractive surgery, the cornea becomes thinner and, therefore, the IOP measurement is
affected [47,48]. Because most patients undergoing laser refractive surgery are myopic and
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at increased risk for glaucoma [28], the effect of these procedures on glaucoma management
should be determined.
After laser ablation, the corneal thickness and shape change, so the mathematical assump‐
tions used in existing models for IOP measurement cannot be satisfied [49]. In lamellar pro‐
cedures, creation of a corneal flap changes the corneal biomechamical stability. The depth-
dependent tensile strength of the cornea, also have been reported [50,51], with the anterior
40% of stroma having a significantly higher tensile strength than the posterior 60%; there‐
fore, a corneal flap can have viscoelastic properties that differ from the underlying stroma
and further affect the GAT IOP readings. Patients who underwent LASIK and laser-assisted
subepithelial keratomileusis seem to have a postoperative decrease in CH [52,53].
In some cases, LASIK is associated with the interface fluid syndrome (IFS), first described by
Rehany et al. [54], that is characterized by fluid collection in the flap interface due to a
marked IOP increase. The resultant GAT IOP value is falsely lower [48]. In normal corneas
with intact functioning membranes and avascular compact corneal stroma, the stroma bears
the acute IOP increases, and the fluid flows from the stroma to the epithelium, which has
lower pressure, resulting in epithelial edema. After LASIK, there is a virtual space between
the flap and the stromal bed, with fluid accumulating in the flap interface [55].
7. Cornea, lamina cribrosa, and glaucoma
The lamina cribrosa is a sieve-like fenestrated structure in the posterior sclera through
which the optic nerve fibers and the retinal vessels enter and exit the eye. The glial segment
of the optic nerve and lamina cribrosa derive from the neuroectoderm, and the mesenchyme
originates from the neural crest. Because the corneal stroma and the corneal endothelium al‐
so derive from the neural crest, they are related embryologically. The lamina cribrosa is be‐
lieved to be the site at which the neural damage induced by glaucoma occurs.
The CCT may reflect the scleral and lamina cribrosa properties associated with glaucoma‐
tous optic neuropathy. In fact, the CCT is correlated with the anterior scleral thickness in pa‐
tients with POAG [56]. Several studies have assessed the relationship between the CCT and
objectively measured optic disc parameters, but they provide inconsistent results. Using the
confocal scanning laser ophthalmoscopy (Heidelberg Retina Tomograph, Heidelberg Engi‐
neering, Heidelberg, Germany), several hospital-based studies of patients with glaucoma
have suggested that the CCT is correlated with the optic disc area and nasal rim volume
[57], while another population-based study [58] did not identify these correlations. In anoth‐
er population-based survey [59], no significant relationship was found between the CCT and
ONH parameters obtained with retinal tomography.
Thin corneas also can be associated with weak ONHs and this weakness may be related with a
thin lamina cribrosa [60-62]. Further, the development and progression of glaucoma are corre‐
lated with the CCT [62]. Other studies have suggested that CH and not corneal thickness is cor‐
related with the vulnerability of the ONH to sustain glaucomatous damage [63].
Glaucoma - Basic and Clinical Aspects238
The correlation between CCT and ONH topographic changes in response to IOP reductions
in patients with POAG also has been evaluated [64]. The hypothesis was that thinner CCTs
might be associated with greater changes in ONH topography due to a more compliant lam‐
ina cribrosa. Nicolela et al. [65] found that patients with thinner corneas show significantly
greater cup shallowing, which is a surrogate marker for lamina cribrosa displacement and
compliance in response to IOP reduction. The investigators interrupted the medical treat‐
ment for 4 weeks (with an average increase of IOP of 5.4 mmHg), and when the medical
treatment was restarted, the IOPs were remeasured after 4 weeks, and they found that the
IOP decreased from a mean of 22.27±4.12 mmHg to a mean of 17.39±2.67 mmHg. This
finding may support the hypothesis that eyes with a thinner CCT have an increased risk of
developing glaucomatous ONH changes because the lamina cribrosa may be more prone to
displacement in response to IOP changes. Nevertheless, the changes of the ONH topogra‐
phy were unconfirmed [65] for relatively moderate IOP changes of about 5 mmHg. In addi‐
tion, the stage of the ONH glaucomatous damage and the disease duration might affect the
degree of compliance of the lamina in response to IOP changes, so that for more advanced
and long-standing damage less compliance of the lamina can be expected.
The differences in laminar thickness have been studied in different glaucoma types. Park et al.
[66] reported that NTG was associated with a thinner lamina cribosa than OAG in patients with
a similar disease stage; another study showed that patients with pseudoexfoliation syndrome
have less stiffness compared with normal controls, which may reflect an inherent tissue weak‐
ness that makes these eyes more vulnerable to glaucomatous damage [67].
Researchers generally agree that the lamina cribrosa is important in glaucoma [68]. Never‐
theless, in vivo clinical clues regarding the correlated parameters of the lamina cribrosa are
limited [69, 70].
8. Effect of topical hypotensive drugs on the cornea
Some ocular hypotensive drugs, such as topical carbonic anhydrase inhibitors (CAIs) and
F2α-prostaglandin analogs (PGAs), induce changes in the CCT [71].
The hypotensive effect of PGAs, first-line treatments of glaucoma and OHT, may be affected
by some ocular characteristics, such as the axial length [72]. Eyes with a longer axial length
have a worse response to PGAs treatment. If a patient had undergone a previous argon laser
trabeculoplasty, there is a minimal response to a PGA [73]. In addition to its effectiveness in
lowering IOP, PGAs have mild and local side effects that include changes in iris color in up
to 70% of patients [74], especially in patients with mixed colors and in the irises of older pa‐
tients [75]. The changes in iris pigmentation are related to increased melanin content of the
iris melanocytes [76]. Other side effects are periocular hyperpigmentation and darkening
and increased eyelash length. PGAs are highly efficient for lowering IOP, with few local and
systemic side effects. Interestingly, most recent studies have shown that PGAs decrease the
CCT, and Viestenz et al. [77] reported thinner CCTs in patients treated with topical prosta‐
glandin F2-alpha, compared with topical CAIs. Harasymowycz et al. in a prospective study
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[78] found a mean 6.9-micron CCT decrease after 6 weeks of travoprost treatment. Sen et al.
[79] reported 1.9 ± 2.4% and 2.8 ± 1.8% CCT decreases over 24 months with latanoprost and
bimatoprost, respectively. Hatanaka et al. [80] also reported that topical PGAs were associat‐
ed with a CCT reduction over at least 8 weeks (the bimatoprost 0.03% group decreased from
544.41 ± 35.4 to 540.35 ± 35.9 µm; the travoprost 0.004% group decreased from 538.47 ± 32.0
to 532.25 ± 30.4 µm; the latanoprost 0.005% group decreased from 548.57 ± 32.4 to 543.88 ±
35.6 µm). Zhong et al. [81] reported CCT reductions in the latanoprost, travoprost, and bi‐
matoprost groups of 14.95 ± 5.04, 15.73 ± 3.25, and 17.00 ± 6.23 mm, respectively, and no sig‐
nificant difference was seen in the CCT reductions between patients with 6 months or
shorter treatment and patients with 6 months or longer treatment in the three groups.
The reason for the effect of the PGAs on the CCT is unknown, but it is widely accepted that PGAs
seem to induce ECM remodeling due to a FP-receptor-mediated increased synthesis of matrix
metalloproteinases (MMPs) [82]. The MMPs are a family of enzymes that degrade several com‐
ponents of the ECM, thus decreasing the levels of collagen types I, II, III, and IV. Published evi‐
dence suggests that the PGA-related activation of the MMPs activity takes place in the ciliary
body, the trabecular meshwork [83], the conjunctiva, the sclera, and the zonular fibers-ciliary
muscle complex [84]. Further, naturally occurring prostaglandins seem to play a relevant role in
physiologic corneal conditions, i.e., repair after corneal injuries, and in pathologic corneal con‐
ditions, i.e., corneal ectasia. In fact, PGA treatment may be related to keratoconus progression
[85]. Thus, there is enough evidence to suggest that topical PGAs might induce changes in the
ECM of the corneal stroma via up-regulation of MMPs that may slightly change the CCT and
perhaps the corneal viscoelastic properties. In fact, CH seems to be significantly lower in PGA-
treated eyes [86]. PGAs also seem to increase the keratocyte density in the corneal stroma, which
might also result in changes in the ECM [87].
Previous reports have suggested that chronic topical PGA treatment is associated with a
slight decrease in the CCT [86,88] and an increase in the CH. We studied the response of
CCT to increased IOP in rabbit eyes treated with travoprost for 1 month and in an untreated
control group, and found that the decrease in CCT induced by a sudden increase in IOP was
greater in the PGA-treated eyes than in the control eyes [88]. The changes in corneal thick‐
ness induced by IOP increases are believed to be a strain response and thus are probably a
biomechanical response of the corneal tissue to the IOP changes. Then the differences in the
CCT behavior between groups also suggest that PGAs induce changes in the corneal biome‐
chanical properties, at least in rabbits.
Topical dorzolamide induces a 14.4% increase in CCT in patients with corneal guttata [89].
Patients with severe corneal guttata or a highly compromised endothelial function may have
a higher risk of corneal decompensation after prolonged topical use of dorzolamide.
Dorzolamide is a potent cytosolic carbonic anhydrase inhibitor (CAI) isoenzyme II, and the cor‐
neal endothelium contains carbonic anhydrase (CA) II and the cytosolic CA I, which plays a ma‐
jor role in keeping the cornea relatively dehydrated. Dorzolamide has a high affinity for CA II
and low affinity for CA I, and thus, it has the potential to interfere with the pump function of the
corneal endothelium, which could theoretically lead to corneal edema. Changes in CCT have
been used as an indirect indicator of the endothelial function. Some investigations have report‐
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ed a slight but significant increase in CCT in eyes treated with brinzolamide, another CAI inhibi‐
tor [90]. Another way to measure the endothelial function in vivo is to measure the intrastromal
corneal pressure [91,92], formerly known as corneal intrastromal pressure, which has a negative
value under physiologic conditions. The amount of negative pressure in the corneal stroma is
likely to be correlated with the endothelial function, and topical dorzolamide significantly re‐
duces the negative pressure in the corneal stroma in rabbits [91], suggesting that the drug affects
the endothelial function in healthy rabbit corneas. This finding is consistent with the reported
cases of dorzolamide-induced corneal edema in susceptible patients and with the finding that
inhibiting CA in the corneal endothelium causes a 50% decrease in the endothelial fluid trans‐
port and some corneal swelling [92].
9. Conclusion
There is growing interest in the possible effect of some corneal parameters in glaucoma.
There is sufficient evidence to suggest that CCT evaluation predicts the risk of conversion
from OHT to glaucoma. The influence of the CCT on the GAT IOP is clear, so true IOP is
higher than GAT IOP in patients with thinner corneas and true IOP is lower than GAT IOP
in patients with thicker corneas. In addition, some data suggest that CCT may be an inde‐
pendent risk factor for glaucoma development, although there is no clear evidence to sup‐
port this hypothesis.
Of special interest is the fact that GAT is affected by laser excimer refractive surgery, a pop‐
ular procedure that changes some corneal properties that affect accurate IOP measurement.
New tonometers with a lower relationship to the corneal thickness and viscoelastic proper‐
ties need to be developed.
Finally, widely used topical antiglaucomatous medications can alter the corneal viscoelastic
properties and thus affect the GAT readings. This also needs to be investigated further.
Author details
Gema Bolivar1, Javier Paz Moreno-Arrones1* and Miguel A. Teus2
*Address all correspondence to: javierpazmoreno@gmail.com
1 Department of Glaucoma, Hospital Universitario Príncipe de Asturias, Alcalá de Henares,
Spain
2 Department of Ophthalmology, Hospital Universitario Príncipe de Asturias, University of
Alcalá, Alcalá de Henares, Spain
Cornea and Glaucoma
http://dx.doi.org/10.5772/53017
241
References
[1] Congdon N, O’Colmain B, Klaver CC, et al. Causes and prevalence of visual impair‐
ment among adults in the United States. Arch Ophthalmol 2004;122(4):477– 485.
[2] Friedman DS, Wolfs RC, O’Colmain BJ, et al. Prevalence of open-angle glaucoma
among adults in the United States. Arch Ophthalmol 2004;122(4):532–538.
[3] Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment
Study: a randomized trial determines that topical ocular hypotensive medication de‐
lays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol
2002;120(6):701–713, discussion 829-830.
[4] Collaborative Initial Normal-Tension Glaucoma Study Group. Comparison of glau‐
comatous progression between untreated patients with normal-tension glaucoma
and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol
1998;126(4):487– 497.
[5] Aoyama A, Ishida K, Sawada A, Yamamoto T. Target intraocular pressure for stabili‐
ty of visual field loss progression in normal-tension glaucoma. Jpn J Ophthalmol.
2010 Mar;54(2):117-23. Epub 2010 Apr 18.
[6] The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between
control of intraocular pressure and visual field deterioration. Am J Ophthalmol 2000;
130(4):429–440.
[7] Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glauco‐
ma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol
2002; 120(10):1268 –1279.
[8] Doughty MJ, Zaman ML. Human corneal thickness and its impact on intraocular
pressure measures: a review and metaanalysis approach. Surv Ophthalmol
2000;44(5):367– 408.
[9] Liu J, Roberts CJ. Influence of corneal biomechanical properties on intraocular pres‐
sure measurement: quantitative analysis. J Cataract Refract Surg 2005;31(1):146 –155.
[10] Medeiros FA, Weinreb RN. Evaluation of the influence of corneal biomechanical
properties on intraocular pressure measurements using the ocular response analyzer.
J Glaucoma 2006;15(5):364 –370.
[11] Turss R, Schebitz H.Significance of the aqueous humor and marginal loop vessels for
the nutrition of the cornea. Ber Zusammenkunft Dtsch Ophthalmol Ges.
1972;71:87-91.
[12] Bonanno JA. Molecular mechanisms underlying the corneal endothelial pump. Exp
Eye Res. 2012 Feb;95(1):2-7.
[13] Lester M, Mete M, Figus M, Frezzotti P. Incorporating corneal pachymetry into the
management of glaucoma. J Cataract Refract Surg. 2009 Sep;35(9):1623-8.
Glaucoma - Basic and Clinical Aspects242
[14] Ocular Hypertension Treatment Study Group and the European Glaucoma Preven‐
tion Study Group. The accuracy and clinical application of predictive models for pri‐
mary open-angle glaucoma in ocular hypertensive individuals.Ophthalmology. 2008
Nov;115(11):2030-6.
[15] Ehlers N, Bramsen T, Sperling S. Applanation tonometry and central corneal thick‐
ness. Acta Ophthalmol (Copenh) 1975; 53:34–43.
[16] Dueker DK, Singh K, Lin SC, Fechtner RD, Minckler DS, Samples JR, Schuman JS.
Corneal thickness measurement in the management of primary open-angle glauco‐
ma: a report by the American Academy of Ophthalmology. Ophthalmology. 2007
Sep;114(9):1779-87.
[17] Whitacre MM, Stein RA, Hassanein K. The effect of corneal thickness on applanation
tonometry. Am J Ophthalmol 1993; 115:592– 6.
[18] Shimmyo M, Ross AJ, Moy A, Mostafavi R. Intraocular pressure, Goldmann applana‐
tion tension, corneal thickness, and corneal curvature in Caucasians, Asians, Hispan‐
ics, and African Americans. Am J Ophthalmol 2003;136:603–13.
[19] Brandt JD, Gordon MO, Gao F, et al. Adjusting intraocular pressure for central cor‐
neal thickness does not improve prediction models for primary open-angle glauco‐
ma. Ophthalmology 2012;119:437– 42.
[20] Park SJ, Ang GS, Nicholas S, Wells AP. The effect of thin, thick, and normal corneas
on Goldmann intraocular pressure measurements and correction formulae in indi‐
vidual eyes. Ophthalmology. 2012 Mar;119(3):443-9.
[21] Gordon MO, Torri V, Miglior S, et al. Validated prediction model for the develop‐
ment of primary open-angle glaucoma in individuals with ocular hypertension. Oph‐
thalmology 2007; 114:10 –9.
[22] Hernandez-Verdejo JL, Teus MA, Roman JM, Bolivar G. Porcine model to compare
real-time intraocular pressure during LASIK with a mechanical microkeratome and
femtosecond laser. Invest Ophthalmol Vis Sci. 2007 Jan;48(1):68-72.
[23] Boehm AG, Weber A, Pillunat LE, et al. Dynamic contour tonometry in comparison
to intracameral IOP measurements. Invest Ophthalmol Vis Sci 2008;49:2472–7.
[24] Jordan JF, Joergens S, Dinslage S, Dietlein TS, Krieglstein GK. Central and paracen‐
tral corneal pachymetry in patients with normal tension glaucoma and ocular hyper‐
tension. Graefes Arch Clin Exp Ophthalmol. 2006 Feb;244(2):177-82.
[25] Goldmann H, Schmidt T. Uber applanationstonometrie. Ophthalmologie
1957;134:221–42
[26] Medeiros FA, Weinreb RN. Is corneal thickness an independent risk factor for glau‐
coma? Ophthalmology. 2012 Mar;119(3):435-6.
Cornea and Glaucoma
http://dx.doi.org/10.5772/53017
243
[27] Brandt JD, Gordon MO, Beiser JA, Lin SC, Alexander MY, Kass MA. Changes in cen‐
tral corneal thickness over time: the ocular hypertension treatment study. Ocular Hy‐
pertension Treatment Study Group. Ophthalmology. 2008 Sep;115(9):1550-6, 1556
[28] Brandt JD. Central corneal thickness, tonometry, and glaucoma risk-a guide for the
perplexed. Can J Ophthalmol. 2007 Aug;42(4):562-6.
[29] Leske MC, Heijl A, Hyman L, et al, EMGT Group. Predictors of long-term progres‐
sion in the Early Manifest Glaucoma Trial. Ophthalmology 2007;114:1965–72.
[30] Leske MC, Wu SY, Hennis A, et al, BESs Study Group. Risk factors for incident open-
angle glaucoma: the Barbados Eye Studies. Ophthalmology 2008;115:85–93.
[31] Francis BA, Varma R, Chopra V, et al, Los Angeles Latino Eye Study Group. Intraoc‐
ular pressure, central corneal thickness, and prevalence of open-angle glaucoma: the
Los Angeles Latino Eye Study. Am J Ophthalmol 2008;146:741– 6.
[32] Seiler T, Quurke AW. Iatrogenic keratectasia after LASIK in a case of forme fruste
keratoconus. J Cataract Refract Surg. 1998;24: 1007–1009.
[33] Jaycock PD, Lobo L, Ibrahim J, Tyrer JR, Marshall J. Interferometric technique to
measure biomechanical changes in the cornea induced by refractive surgery. J Cata‐
ract Refract Surg. 2005;31:175–184
[34] Elsheikh A, Wang D, Brown M, Rama P, Campanelli M, Pye D. Assessment of cor‐
neal biomechanical properties and their variation with age. Curr Eye Res. 2007;32:11–
19.
[35] Ytteborg J. Further investigations of factors influencing size of rigidity coefficient. Ac‐
ta Ophthalmologica. 1960;38:643–657.
[36] Pallikaris IG, Kymionis GD, Ginis HS, Kounis GA, Tsilimbaris MK. Ocular rigidity in
living human eyes. Invest Ophthalmol Vis Sci. 2005;46:409–414.
[37] Randleman JB, Dawson DG, Grossniklaus HE, McCarey BE, Edelhauser HF. Depth-
dependent cohesive tensile strength in human donor corneas: implications for refrac‐
tive surgery. J Refract Surg. 2008;24:S85–89.
[38] Nyquist GW. Rheology of the cornea: experimental techniques and results. Exp Eye
Res. 1968;7:183–188.
[39] Hjortdal JO. Extensibility of the normo-hydrated human cornea. Acta Ophthalmol
Scand. 1995;73:12–17.
[40] Jue B, Maurice DM. The mechanical properties of the rabbit and human cornea. J Bio‐
mech. 1986;19:847–853
[41] Touboul D, Roberts C, Kérautret J, Garra C, Maurice-Tison S, Saubusse E, Colin J.
Correlations between corneal hysteresis, intraocular pressure, and corneal central pa‐
chymetry. J Cataract Refract Surg. 2008 Apr;34(4):616-22.
Glaucoma - Basic and Clinical Aspects244
[42] Kotecha A, White ET, Shewry JM, Garway-Heath DF. The relative effects of corneal
thickness and age on Goldmann applanation tonometry and dynamic contour ton‐
ometry. Br J Ophthalmol. 2005 Dec;89(12):1572-5.
[43] Detry-Morel M, Jamart J, Pourjavan S. Evaluation of corneal biomechanical proper‐
ties with the Reichert Ocular Response Analyzer. Eur J Ophthalmol. 2011 Mar-Apr;
21(2):138-48.
[44] Kotecha A. What biomechanical properties of the cornea are relevant for the clini‐
cian? Surv Ophthalmol. 2007 Nov;52 Suppl 2:S109-14.
[45] Bochmann F, Ang GS, Azuara-Blanco A. Lower corneal hysteresis in glaucoma pa‐
tients with acquired pit of the optic nerve (APON). Graefes Arch Clin Exp Ophthal‐
mol. 2008 Jan 12.
[46] Kotecha A, Elshkeikh A, Roberts CR, Zhu H, Garway-Heath DF. Properties of the
cornea measured with the ocular response analyzer. Invest Ophthalmol Vis Sci 2006;
47: 5337-5347.
[47] Chatterjee A, Shah S, Bessant DA, Naroo SA, Doyle SJ. Reduction in intraocular pres‐
sure after excimer laser photorefractive keratectomy: correlation with pretreatment
myopia. Ophthalmology 1997;104:355–359.
[48] Munger R, Hodge WG, Mintsioulis G, Agapitos PJ, Jackson WB, Damji KF. Correc‐
tion of intraocular pressure for changes in central corneal thickness following photo‐
refractive keratectomy. Can J Ophthalmol 1998;33:159 –165.
[49] Wells AP, Garway-Heath DF, Poostchi A, Wong T, Chan KC, Sachdev N. Corneal
hysteresis but not corneal thickness correlates with optic nerve surface compliance in
glaucoma patients. Invest Ophthalmol Vis Sci. 2008 Aug;49(8):3262-8.
[50] Randleman JB, Dawson DG, Grossniklaus HE, McCarey BE, Edelhauser HF. Depth-
dependent cohesive tensile strength in human donor corneas: implications for refrac‐
tive surgery. J Refract Surg 2008; 24:S85–S89
[51] Dawson DG, Grossniklaus HE, McCarey BE, Edelhauser HF. Biomechanical and
wound healing characteristics of corneas after excimer laser keratorefractive surgery:
is there a difference between advanced surface ablation and sub-Bowman’s kerato‐
mileusis? J Refract Surg 2008; 24:S90–S96).
[52] Qazi MA, Sanderson JP, Mahmoud AM, Yoon EY, Roberts CJ, Pepose JS. Postopera‐
tive changes in intraocular pressure and corneal biomechanical metricsLaser in situ
keratomileusis versus laser-assisted subepithelial keratectomy. J Cataract Refract
Surg. 2009 Oct;35(10):1774-88.
[53] Kirwan C, O'Keefe M. Corneal hysteresis using the Reichert ocular response analy‐
ser: findings pre- andpost-LASIK and LASEK. Acta Ophthalmol. 2008 Mar;86(2):
215-8. Epub 2007 Sep 21.
Cornea and Glaucoma
http://dx.doi.org/10.5772/53017
245
[54] Rehany U, Bersudsky V, Rumelt S. Paradoxical hypotony after laser in situ keratomi‐
leusis. J Cataract Refract Surg. 2000 Dec;26(12):1823-6.
[55] Carreño E, Portero A, Galarreta DJ, Merayo JM.Interface fluid syndrome associated
with cataract surgery. J Refract Surg. 2012 Apr;28(4):243-4.
[56] Mohamed-Noor J, Bochmann F, Siddiqui MA, Atta HR, Leslie T, Maharajan P, Wong
YM, Azuara-Blanco A. Correlation between corneal and scleral thickness in glauco‐
ma. J Glaucoma. 2009 Jan;18(1):32-6.
[57] Terai N, Spoerl E, Pillunat LE, Kuhlisch E, Schmidt E, Boehm AG. The relationship
between central corneal thickness and optic disc size in patients with primary open-
angle glaucoma in a hospital-based population. Acta Ophthalmol. 2011 Sep;89(6):
556-9.
[58] Tomidokoro A, Araie M, Iwase A; Tajimi Study Group. Corneal thickness and relat‐
ing factors in a population-based study in Japan: theTajimi study. Am J Ophthalmol.
2007 Jul;144(1):152-4.
[59] Hawker MJ, Edmunds MR, Vernon SA, Hillman JG, MacNab HK. The relationship
between central corneal thickness and the optic disc in an elderly population: the Bri‐
dlington Eye Assessment Project. Eye (Lond). 2009 Jan;23(1):56-62.
[60] Mokbel TH et al. Correlation of central corneal thickness and optic nerve head topog‐
raphy in patients with primary open-angle glaucoma. Oman J Ophthalmol. (2010)
[61] Cankaya AB et al. Relationship between central corneal thickness and parameters of
optic nerve head topography in healthy subjects. Eur J Ophthalmol. (2008)
[62] Lesk MR et al. Relationship between central corneal thickness and changes of optic
nerve head topography and blood flow after intraocular pressure reduction in open-
angle glaucoma and ocular hypertension. Arch Ophthalmol. (2006)
[63] Insull E, Nicholas S, Ang GS, Poostchi A, Chan K, Wells A.Optic disc area and corre‐
lation with central corneal thickness, corneal hysteresisand ocular pulse amplitude in
glaucoma patients and controls. Clin Experiment Ophthalmol. 2010 Dec;38(9):839-44.
[64] Nemesure B, Wu SY, Hennis A, Leske MC. Factors related to the 4-year risk of high
intraocular pressure: the Barbados Eye Studies. Barbados Eye Studies Group. Arch
Ophthalmol. 2003 Jun;121(6):856-62.
[65] Nicolela MT, Soares AS, Carrillo MM, Chauhan BC, LeBlanc RP, Artes PH. Effect of
moderate intraocular pressure changes on topographic measurements with confocal
scanning laser tomography in patients with glaucoma. Arch Ophthalmol. 2006 May;
124(5):633-40.
[66] Park HY, Jeon SH, Park CK. Enhanced depth imaging detects lamina cribrosa thick‐
ness differences in normal tension glaucoma and primary open-angle glaucoma.
Ophthalmology. 2012 Jan;119(1):10-20.
Glaucoma - Basic and Clinical Aspects246
[67] Braunsmann C, Hammer CM, Rheinlaender J, Kruse FE, Schäffer TE, Schlötzer-
Schrehardt U. Evaluation of lamina cribrosa and peripapillary sclera stiffness in
pseudoexfoliation and normal eyes by atomic force microscopy. Invest Ophthalmol
Vis Sci. 2012 May 17;53(6):2960-7.
[68] Lee EJ, Kim TW, Weinreb RN, Suh MH, Kang M, Park KH, Kim SH, Kim DM. Three-
dimensional evaluation of the lamina cribrosa using spectral-domain optical coher‐
ence tomography in glaucoma. Invest Ophthalmol Vis Sci. 2012 Jan 20;53(1):198-204.
[69] Akagi T, Hangai M, Takayama K, Nonaka A, Ooto S, Yoshimura N. In vivo imaging
of lamina cribrosa pores by adaptive optics scanning laser ophthalmoscopy. Invest
Ophthalmol Vis Sci. 2012 Jun 26;53(7):4111-9.
[70] Kiumehr S, Park SC, Dorairaj S, Teng CC, Tello C, Liebmann JM, Ritch R. In Vivo
Evaluation of Focal Lamina Cribrosa Defects in Glaucoma. Arch Ophthalmol. 2012
Jan 9.
[71] Viestenz A, Martus P, Schlötzer-Schrehardt U, Langenbucher A, Mardin CY. Impact
of prostaglandin-F(2alpha)-analogues and carbonic anhydrase inhibitors oncentral
corneal thickness. A cross-sectional study on 403 eyes. Klin Monbl Augenheilkd.
2004 Sep;221(9):753-6.
[72] Arranz-Marquez E, Teus MA. Relation between axial length of the eye and hypoten‐
sive effect of latanoprost in primary open angle glaucoma. Br J Ophthalmol. 2004
May;88(5):635-7.
[73] Arranz-Marquez E, Teus MA. Effect of previous argon laser trabeculoplasty on the
ocular hypotensive action of latanoprost. Graefes Arch Clin Exp Ophthalmol. 2006
Sep;244(9):1073-6.
[74] Teus MA, Arranz-Marquez E, Lucea-Suescun P. Incidence of iris colour change in la‐
tanoprost treated eyes. Br J Ophthalmol. 2002 Oct;86(10):1085-8.
[75] Arranz-Marquez E, Teus MA. Effect of age on the development of a latanoprost-in‐
duced increase in iris pigmentation. Ophthalmology. 2007 Jul;114(7):1255-8.
[76] Arranz-Marquez E, Teus MA, Saornil MA, Mendez MC, Gil R. Analysis of irises with
a latanoprost-induced change in iris color. Am J Ophthalmol. 2004 Oct;138(4):625-30.
[77] Viestenz A, Martus P, Schlötzer-Schrehardt U, Langenbucher A, Mardin CY. [Impact
of prostaglandin-F(2alpha)-analogues and carbonic anhydrase inhibitors on central
corneal thickness -- a cross-sectional study on 403 eyes]. Klin Monbl Augenheilkd.
2004 Sep;221(9):753-6.
[78] Harasymowycz PJ, Papamatheakis DG, Ennis M, Brady M, Gordon KD; Travoprost
Central Corneal Thickness Study Group. Relationship between travoprost and cen‐
tral corneal thickness in ocular hypertension and open-angle glaucoma. Cornea. 2007
Jan;26(1):34-41.
Cornea and Glaucoma
http://dx.doi.org/10.5772/53017
247
[79] Sen E, Nalcacioglu P, Yazici A, Aksakal FN, Altinok A, Tuna T, Koklu G. Compari‐
son of the effects of latanoprost and bimatoprost on central corneal thickness. J Glau‐
coma. 2008 Aug;17(5):398-402.
[80] Hatanaka M, Vessani RM, Elias IR, Morita C, Susanna R Jr. The effect of prostaglan‐
din analogs and prostamide on central corneal thickness. J Ocul Pharmacol Ther.
2009 Feb;25(1):51-3.
[81] Zhong Y, Shen X, Yu J, Tan H, Cheng Y. The comparison of the effects of latanoprost,
travoprost, and bimatoprost on central corneal thickness. Cornea. 2011 Aug;30(8):
861-4.
[82] Lopilly Park HY, Kim JH, Lee KM, Park CK. Effect of prostaglandin analogues on
tear proteomics and expression of cytokines and matrix metalloproteinases in the
conjunctiva and cornea. Exp Eye Res. 2012 Jan;94(1):13-21
[83] Weinreb RN, Toris CB, Gabelt BT, Lindsey JD, Kaufman PL. Effects of prostaglandins
on the aqueous humor outflow pathways. Surv Ophthalmol. 2002 Aug;47 Suppl
1:S53-64.
[84] Crowston JG, Aihara M, Lindsey JD, Weinreb RN. Effect of latanoprost on outflow
facility in the mouse. Invest Ophthalmol Vis Sci. 2004 Jul;45(7):2240-5.
[85] Amano S, Nakai Y, Ko A, Inoue K, Wakakura M. A case of keratoconus progression
associated with the use of topical latanoprost. Jpn J Ophthalmol. 2008 Jul-Aug;52(4):
334-6.
[86] Agarwal DR, Ehrlich JR, Shimmyo M, Radcliffe NM. The relationship between cor‐
neal hysteresis and the magnitude of intraocular pressure reduction with topical
prostaglandin therapy. Br J Ophthalmol. 2012 Feb;96(2):254-7.
[87] Bergonzi C, Giani A, Blini M, Marchi S, Luccarelli S, Staurenghi G. Evaluation of
prostaglandin analogue effects on corneal keratocyte density using scanning laser
confocal microscopy. J Glaucoma. 2010 Dec;19(9):617-21.
[88] Bolívar G, Teus M, Arranz-Marquez E. Effect of acute increases of intraocular pres‐
sure on corneal pachymetry in eyes treated with travoprost: an animal study. Curr
Eye Res. 2011 Nov;36(11):1014-9.
[89] Wirtitsch MG, Findl O, Heinzl H, Drexler W. Effect of dorzolamide hydrochloride on
central corneal thickness in humans with cornea guttata. Arch Ophthalmol. 2007 Oct;
125(10):1345-50
[90] Ornek K, Gullu R, Ogurel T, Ergin A. Short-term effect of topical brinzolamide on
human central corneal thickness. Eur J Ophthalmol. 2008 May-Jun;18(3):338-40.
[91] Teus MA, Bolívar G, Alió JL, Lipshitz I. Short-term effect of topical dorzolamide hy‐
drochloride on intrastromal cornealpressure in rabbit corneas in vivo. Cornea. 2009
Feb;28(2):206-10.
Glaucoma - Basic and Clinical Aspects248
[92] Bolívar G, Teus MA, Hernández-Verdejo JL. Short-term effect of topical brimonidine
tartrate on intrastromal corneal pressure in rabbits. J Refract Surg. 2010 Jul;26(7):
533-5. Surg 201;26(7):533-535.
Cornea and Glaucoma
http://dx.doi.org/10.5772/53017
249

